Cenk Uygur
@TheYoungTurks·6.5M subscribers·72.8K videos
Actemra's Failure to Warn of Serious Side Effects Leads to Thousands of Potential Lawsuits
Posted
August 12, 2017
Views
12,517
Likes
340
Comments
40
Engagement
August 12, 2017
12,517
340
40
3.04%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
7:36Now PlayingActemra is an immunosuppressive medication used to treat the symptoms of moderate to severe rheumatoid arthritis. The medication was first approved by the FDA in 2010. The drug has been marketed to doctors as not increasing the risk of heart failure, stroke and lung disease, which competing drug makers admit their rheumatoid arthritis medication does. The problem is that Actemra does apparently carry this risk, and the manufacturer has misled the FDA and doctors in order to sale its drug. To learn more about the lawsuits involving Actemra, visit
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
